Search Result
Results for "
CRF2
" in MedChemExpress (MCE) Product Catalog:
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-P1752B
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II, human (acetate) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. For investigating the role of the CRF (2) receptor in ingestive behavior .
|
-
-
- HY-RS03171
-
CRF2; CRFR2; CRF-RB; HM-CRF
|
Small Interfering RNA (siRNA)
|
Others
|
CRHR2 Human Pre-designed siRNA Set A contains three designed siRNAs for CRHR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
CRHR2 Human Pre-designed siRNA Set A
CRHR2 Human Pre-designed siRNA Set A
-
- HY-RS06738
-
CRF2X; CRF2-10; CRF2-S1; IL-22BP; IL-22RA2; ZCYTOR16; IL-22R-alpha-2
|
Small Interfering RNA (siRNA)
|
Others
|
IL22RA2 Human Pre-designed siRNA Set A contains three designed siRNAs for IL22RA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
IL22RA2 Human Pre-designed siRNA Set A
IL22RA2 Human Pre-designed siRNA Set A
-
- HY-RS18866
-
Il28ra; CRF2-12
|
Small Interfering RNA (siRNA)
|
Others
|
Ifnlr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ifnlr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
Ifnlr1 Mouse Pre-designed siRNA Set A
Ifnlr1 Mouse Pre-designed siRNA Set A
-
- HY-RS06737
-
IL22R; CRF2-9; IL22R1
|
Small Interfering RNA (siRNA)
|
Others
|
IL22RA1 Human Pre-designed siRNA Set A contains three designed siRNAs for IL22RA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
IL22RA1 Human Pre-designed siRNA Set A
IL22RA1 Human Pre-designed siRNA Set A
-
- HY-RS06595
-
IFNLR; LICR2; IL28RA; CRF2/12; IL-28R1
|
Small Interfering RNA (siRNA)
|
Others
|
IFNLR1 Human Pre-designed siRNA Set A contains three designed siRNAs for IFNLR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
IFNLR1 Human Pre-designed siRNA Set A
IFNLR1 Human Pre-designed siRNA Set A
-
- HY-RS03173
-
CRF2r; CRF-R 2; CRH-R 2
|
Small Interfering RNA (siRNA)
|
Others
|
Crhr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Crhr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
Crhr2 Rat Pre-designed siRNA Set A
Crhr2 Rat Pre-designed siRNA Set A
-
- HY-RS06732
-
CRF2-8; IL-20R1; IL-20RA; IL-20R-alpha
|
Small Interfering RNA (siRNA)
|
Others
|
IL20RA Human Pre-designed siRNA Set A contains three designed siRNAs for IL20RA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
IL20RA Human Pre-designed siRNA Set A
IL20RA Human Pre-designed siRNA Set A
-
- HY-RS06674
-
CRFB4; IBD25; CRF2-4; D21S58; D21S66; CDW210B; IL-10R2; IL-10RB
|
Small Interfering RNA (siRNA)
|
Others
|
IL10RB Human Pre-designed siRNA Set A contains three designed siRNAs for IL10RB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
IL10RB Human Pre-designed siRNA Set A
IL10RB Human Pre-designed siRNA Set A
-
- HY-P1108
-
|
CFTR
|
Others
|
Astressin 2B is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B antagonizes CRF2-mediated inhibition of gastric emptying [2] .
|
-
-
- HY-P1108A
-
|
CFTR
|
Others
|
Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B TFA antagonizes CRF2-mediated inhibition of gastric emptying [2] .
|
-
-
- HY-P1106A
-
|
CFTR
|
Cardiovascular Disease
|
K41498 TFA is a potent and highly selective CRF2 receptor antagonist with Ki values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively. K41498 TFA is an analogues of antisauvagine-30 (aSvg-30), inhibits sauvagine-stimulated cAMP accumulation in hCRF2α- and hCRF2β-expressing cells. K41498 TFA can be used for hypotension study .
|
-
-
- HY-P1294
-
|
CRFR
|
Neurological Disease
|
α-Helical CRF(9-41) is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) is also a partial agonist of CRF1 receptor with an EC50 of 140 nM [2].
|
-
-
- HY-P1294A
-
|
CRFR
|
Neurological Disease
|
α-Helical CRF(9-41) TFA is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) TFA is also a partial agonist of CRF1 receptor with an EC50 of 140 nM [2].
|
-
-
- HY-P3597
-
|
CFTR
|
Others
|
Urocortin III (mouse) (free acid) is a selective CRF2 receptor agonist (with high affinity for the CRF2 receptor). Urocortin III (mouse) (free acid) significantly inhibits gastric emptying without modifying colonic transit [2].
|
-
-
- HY-P1752
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II (human) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. For investigating the role of the CRF (2) receptor in ingestive behavior .
|
-
-
- HY-P1752A
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II, human (TFA) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. For investigating the role of the CRF (2) receptor in ingestive behavior .
|
-
-
- HY-P1107
-
aSvg-30
|
CRFR
|
Neurological Disease
|
Antisauvagine-30 (aSvg-30) is a potent, competitive and selective CRF2 receptor antagonist with Kd values of 1.4 nM and 153.6 nM for mouse CRF2β and rat CRF1 receptors, respectively .
|
-
-
- HY-14875
-
GSK561679
|
CRFR
|
Neurological Disease
Endocrinology
|
Verucerfont is a corticotropin-releasing factor receptor 1 (CRF1) antagonist with IC50s of ~6.1, >1000 and >1000?nM for CRF1, CRF2, and CRF-BP, respectively.
|
-
-
- HY-P2847
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II, mouse is a potent and selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor with Ki values of 0.66 nM and ﹥100 nM for CRFR2 and CRFR1, respectively. Urocortin II, mouse activates CRF2 receptors in a cAMP/PKA- and Ca 2+/CaMKII-dependent manner.Urocortin II, mouse is expressed in discrete areas of the central nervous system, and activates central neurons involved in the processing of visceral sensory information, and in modulating autonomic outflow [2] .
|
-
-
- HY-P1295
-
Urocortin (human); Human urocortin; Human urocortin 1; Human urocortin I
|
CRFR
|
Neurological Disease
Endocrinology
|
Urocortin, human, a 40-aa neuropeptide, acts as a selective agonist of endogenous CRF2 receptor, with Kis of 0.4, 0.3, and 0.5 nM for hCRF1, rCRF2α and mCRF2β, respectively.
|
-
-
- HY-P1106
-
|
CRFR
|
Cardiovascular Disease
|
K41498 is a potent and highly selective CRF2 receptor antagonist with Ki values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively. K41498 is an analogues of antisauvagine-30 (aSvg-30), inhibits sauvagine-stimulated cAMP accumulation in hCRF2α- and hCRF2β-expressing cells. K41498 can be used for hypotension study .
|
-
-
- HY-12129
-
|
CFTR
|
Neurological Disease
|
CP 154526 hydrochloride is a potent, brain-penetrant and selective corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki of 2.7 nM. CP 154526 hydrochloride shows selective for CRF1 over CRF2 (Ki = >10 μM). CP 154526 hydrochloride has anxiolytic activities [2].
|
-
-
- HY-12130
-
|
CRFR
|
Neurological Disease
|
CP 154526 is a potent, brain-penetrant and selective corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki of 2.7 nM. CP 154526 shows selective for CRF1 over CRF2 (Ki = >10 μM). CP 154526 has anxiolytic activities [2].
|
-
-
- HY-P1107A
-
aSvg-30 TFA
|
CRFR
|
Neurological Disease
|
Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF2 receptor peptidic antagonist. Antisauvagine-30 TFA exhibits a Kd of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively [2] .
|
-
-
- HY-P1542
-
Catostomus urotensin I
|
CRFR
|
Cardiovascular Disease
Endocrinology
|
Urotensin I (Catostomus urotensin I), a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively [2].
|
-
-
- HY-14128
-
SB-723620
|
CRFR
|
Neurological Disease
|
NBI-34041 (SB-723620) is a selective and orally active nonpeptide CRF1 receptor antagonist with an IC50 of 58.9 nM and a Ki of 4.0 nM for human CRF1 receptor. NBI-34041 has no inhibitory effect on the CRF2 receptor. NBI-34041 can be used for depression and anxiety disorders research.
|
-
-
- HY-P1542B
-
Catostomus urotensin I TFA
|
CRFR
|
Cardiovascular Disease
Endocrinology
|
Urotensin I (Catostomus urotensin I) TFA, a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively [2].
|
-
-
- HY-110056
-
|
CRFR
|
Neurological Disease
|
NBI 35965 hydrochloride is a selective, orally active and brain-penetrant corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki value of 4 nM and a pKi value of 8.5. NBI 35965 hydrochloride does not inhibit CRF2. NBI 35965 hydrochloride reduces CRF or stress-induced adrenocorticotropic hormone (ACTH) production in vivo with pIC50 values of 7.1 and 6.9, respectively. NBI 35965 hydrochloride shows anxiolytic effects [2].
|
-
-
- HY-103378
-
|
CRFR
|
Neurological Disease
|
NBI 35965 methanesulfonate is a selective, orally active and brain-penetrant corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki value of 4 nM and a pKi value of 8.5. NBI 35965 methanesulfonate does not inhibit CRF2. NBI 35965 methanesulfonate reduces CRF or stress-induced adrenocorticotropic hormone (ACTH) production in vivo with pIC50 values of 7.1 and 6.9, respectively. NBI 35965 methanesulfonate shows anxiolytic effects [2].
|
-
-
- HY-P1296
-
Urocortin (Rattus norvegicus); Rat urocortin
|
CRFR
|
Neurological Disease
Endocrinology
|
Urocortin, rat (Urocortin (Rattus norvegicus)) is a neuropeptide and a potent endogenous CRFR agonist with Kis of 13 nM, 1.5 nM, and 0.97 nM for human CRF1, rat CRF2α and mouse CRF2β, respectively [2].
|
-
-
- HY-P1296A
-
Urocortin (Rattus norvegicus) (TFA); Rat urocortin TFA
|
CRFR
|
Neurological Disease
Endocrinology
|
Urocortin, rat TFA (Urocortin (Rattus norvegicus) TFA) is a neuropeptide and a potent endogenous CRFR agonist with Kis of 13 nM, 1.5 nM, and 0.97 nM for human CRF1, rat CRF2α and mouse CRF2β, respectively [2].
|
-
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P1752B
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II, human (acetate) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. For investigating the role of the CRF (2) receptor in ingestive behavior .
|
-
- HY-P1108A
-
|
CFTR
|
Others
|
Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B TFA antagonizes CRF2-mediated inhibition of gastric emptying [2] .
|
-
- HY-P1106A
-
|
CFTR
|
Cardiovascular Disease
|
K41498 TFA is a potent and highly selective CRF2 receptor antagonist with Ki values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively. K41498 TFA is an analogues of antisauvagine-30 (aSvg-30), inhibits sauvagine-stimulated cAMP accumulation in hCRF2α- and hCRF2β-expressing cells. K41498 TFA can be used for hypotension study .
|
-
- HY-P1294
-
|
CRFR
|
Neurological Disease
|
α-Helical CRF(9-41) is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) is also a partial agonist of CRF1 receptor with an EC50 of 140 nM [2].
|
-
- HY-P1294A
-
|
CRFR
|
Neurological Disease
|
α-Helical CRF(9-41) TFA is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) TFA is also a partial agonist of CRF1 receptor with an EC50 of 140 nM [2].
|
-
- HY-P1752
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II (human) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. For investigating the role of the CRF (2) receptor in ingestive behavior .
|
-
- HY-P2847
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II, mouse is a potent and selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor with Ki values of 0.66 nM and ﹥100 nM for CRFR2 and CRFR1, respectively. Urocortin II, mouse activates CRF2 receptors in a cAMP/PKA- and Ca 2+/CaMKII-dependent manner.Urocortin II, mouse is expressed in discrete areas of the central nervous system, and activates central neurons involved in the processing of visceral sensory information, and in modulating autonomic outflow [2] .
|
-
- HY-P1108
-
|
CFTR
|
Others
|
Astressin 2B is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B antagonizes CRF2-mediated inhibition of gastric emptying [2] .
|
-
- HY-P3597
-
|
CFTR
|
Others
|
Urocortin III (mouse) (free acid) is a selective CRF2 receptor agonist (with high affinity for the CRF2 receptor). Urocortin III (mouse) (free acid) significantly inhibits gastric emptying without modifying colonic transit [2].
|
-
- HY-P1752A
-
|
CRFR
|
Metabolic Disease
Endocrinology
|
Urocortin II, human (TFA) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. For investigating the role of the CRF (2) receptor in ingestive behavior .
|
-
- HY-P1295
-
Urocortin (human); Human urocortin; Human urocortin 1; Human urocortin I
|
CRFR
|
Neurological Disease
Endocrinology
|
Urocortin, human, a 40-aa neuropeptide, acts as a selective agonist of endogenous CRF2 receptor, with Kis of 0.4, 0.3, and 0.5 nM for hCRF1, rCRF2α and mCRF2β, respectively.
|
-
- HY-P1106
-
|
CRFR
|
Cardiovascular Disease
|
K41498 is a potent and highly selective CRF2 receptor antagonist with Ki values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively. K41498 is an analogues of antisauvagine-30 (aSvg-30), inhibits sauvagine-stimulated cAMP accumulation in hCRF2α- and hCRF2β-expressing cells. K41498 can be used for hypotension study .
|
-
- HY-P1542
-
Catostomus urotensin I
|
CRFR
|
Cardiovascular Disease
Endocrinology
|
Urotensin I (Catostomus urotensin I), a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively [2].
|
-
- HY-P1542B
-
Catostomus urotensin I TFA
|
CRFR
|
Cardiovascular Disease
Endocrinology
|
Urotensin I (Catostomus urotensin I) TFA, a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively [2].
|
-
- HY-P1296
-
Urocortin (Rattus norvegicus); Rat urocortin
|
CRFR
|
Neurological Disease
Endocrinology
|
Urocortin, rat (Urocortin (Rattus norvegicus)) is a neuropeptide and a potent endogenous CRFR agonist with Kis of 13 nM, 1.5 nM, and 0.97 nM for human CRF1, rat CRF2α and mouse CRF2β, respectively [2].
|
-
- HY-P1296A
-
Urocortin (Rattus norvegicus) (TFA); Rat urocortin TFA
|
CRFR
|
Neurological Disease
Endocrinology
|
Urocortin, rat TFA (Urocortin (Rattus norvegicus) TFA) is a neuropeptide and a potent endogenous CRFR agonist with Kis of 13 nM, 1.5 nM, and 0.97 nM for human CRF1, rat CRF2α and mouse CRF2β, respectively [2].
|
Cat. No. |
Compare |
Product Name |
Application |
Reactivity |
Compare Products
|
Products |
|
Cat. No. |
|
Host |
|
Reactivity |
|
Application |
|
Dilution Ratio |
|
Molecular Weight |
|
Conjugation |
|
Clonality |
|
Immunogen |
|
Appearance |
|
Isotype |
|
Gene ID |
|
SwissProt ID |
|
Purity |
|
Formulation |
|
Free Sample |
Yes
No
|
Size |
* This product has been "discontinued".
Optimized version of product available:
|
Cat. No. |
Product Name |
|
Classification |
-
- HY-RS03171
-
CRF2; CRFR2; CRF-RB; HM-CRF
|
|
siRNAs
Human Pre-designed siRNA Sets
|
CRHR2 Human Pre-designed siRNA Set A contains three designed siRNAs for CRHR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS06738
-
CRF2X; CRF2-10; CRF2-S1; IL-22BP; IL-22RA2; ZCYTOR16; IL-22R-alpha-2
|
|
siRNAs
Human Pre-designed siRNA Sets
|
IL22RA2 Human Pre-designed siRNA Set A contains three designed siRNAs for IL22RA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS18866
-
Il28ra; CRF2-12
|
|
siRNAs
Mouse Pre-designed siRNA Sets
|
Ifnlr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ifnlr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS06737
-
IL22R; CRF2-9; IL22R1
|
|
siRNAs
Human Pre-designed siRNA Sets
|
IL22RA1 Human Pre-designed siRNA Set A contains three designed siRNAs for IL22RA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS06595
-
IFNLR; LICR2; IL28RA; CRF2/12; IL-28R1
|
|
siRNAs
Human Pre-designed siRNA Sets
|
IFNLR1 Human Pre-designed siRNA Set A contains three designed siRNAs for IFNLR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS03173
-
CRF2r; CRF-R 2; CRH-R 2
|
|
siRNAs
Rat Pre-designed siRNA Sets
|
Crhr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Crhr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS06732
-
CRF2-8; IL-20R1; IL-20RA; IL-20R-alpha
|
|
siRNAs
Human Pre-designed siRNA Sets
|
IL20RA Human Pre-designed siRNA Set A contains three designed siRNAs for IL20RA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
-
- HY-RS06674
-
CRFB4; IBD25; CRF2-4; D21S58; D21S66; CDW210B; IL-10R2; IL-10RB
|
|
siRNAs
Human Pre-designed siRNA Sets
|
IL10RB Human Pre-designed siRNA Set A contains three designed siRNAs for IL10RB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: